help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2006-0419
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abbasi, F.
Right arrow Articles by Reaven, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abbasi, F.
Right arrow Articles by Reaven, P. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Smoking
Related Collections
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 12 5002-5007
Copyright © 2006 by The Endocrine Society

The Relationship between Plasma Adiponectin Concentration and Insulin Resistance Is Altered in Smokers

Fahim Abbasi, Helke M. F. Farin, Cindy Lamendola, Tracey McLaughlin, Eric A. Schwartz, Gerald M. Reaven and Peter D. Reaven

Department of Medicine (F.A., H.M.F.F., C.L., T.M., G.M.R.), Stanford University School of Medicine, Stanford, California 94305; and Medical Research Service (E.A.S., P.D.R.), Division of Endocrinology and Metabolism, Department of Medicine, Carl T. Hayden Veterans Affairs Medical Center, Phoenix, Arizona 85012

Address all correspondence and requests for reprints to: Peter Reaven, M.D., Division of Endocrinology and Metabolism, Department of Medicine (CS-111E), Carl T. Hayden Veterans Affairs Medical Center, 650 East Indian School Road, Phoenix, Arizona 85012. E-mail: peter.reaven{at}med.va.gov.

Context: Low plasma adiponectin concentrations in smokers may contribute to the adverse consequences that occur in these individuals.

Objective: The objective of the study was to define the relationship among smoking, plasma adiponectin concentrations, insulin resistance, and inflammation.

Design: This was a cross-sectional, observational study with a 2 x 2 factorial design and a prospective longitudinal arm.

Setting: The study was conducted at a general clinical research center.

Participants: Apparently healthy smokers (n = 30) and nonsmokers (n = 30), subdivided into insulin resistant (IR) (n = 15) and insulin sensitive (IS) (n = 15) subgroups participated in the study.

Intervention: Intervention included pioglitazone administration for 3 months to 12 IR smokers and eight IS smokers.

Main Outcome Measures: Measures included fasting plasma adiponectin and C-reactive protein (CRP) concentrations and changes in adiponectin after pioglitazone treatment in IR and IS smokers.

Results: Being either a smoker or having insulin resistance was independently associated with lower adiponectin concentrations (P = 0.046 and 0.001, respectively). The difference in mean adiponectin concentration between smokers and nonsmokers did not depend on the insulin resistance status of the subjects. No difference was detected in average CRP concentrations between smokers and nonsmokers (P = 0.18) and between IR and IS subjects (P = 0.13). CRP concentrations were unrelated to adiponectin in smokers (r = –0.05, P = 0.78) and nonsmokers (r = 0.03, P = 0.86). Finally, pioglitazone treatment increased adiponectin concentrations in both IR (P < 0.001) and IS smokers (P = 0.001).

Conclusions: Plasma adiponectin concentrations are lower in smokers and IR subjects and are unrelated to CRP concentrations. These findings suggest that low levels of adiponectin in smokers may be independent of both insulin resistance and a generalized inflammatory response.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
J. W. Sull, H. J. Kim, J. E. Yun, G. Kim, E. J. Park, S. Kim, H. Y. Lee, and S. H. Jee
Serum adiponectin is associated with family history of diabetes independently of obesity and insulin resistance in healthy Korean men and women
Eur. J. Endocrinol., January 1, 2009; 160(1): 39 - 43.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
R. Z. Stolzenberg-Solomon, S. Weinstein, M. Pollak, Y. Tao, P. R. Taylor, J. Virtamo, and D. Albanes
Prediagnostic Adiponectin Concentrations and Pancreatic Cancer Risk in Male Smokers
Am. J. Epidemiol., November 1, 2008; 168(9): 1047 - 1055.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Martin, L. P. Palaniappan, A. C. Kwan, G. M. Reaven, and P. D. Reaven
Ethnic Differences in the Relationship Between Adiponectin and Insulin Sensitivity in South Asian and Caucasian Women
Diabetes Care, April 1, 2008; 31(4): 798 - 801.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society